SAM
AQST icon

Simplify Asset Management’s Aquestive Therapeutics AQST Stock Holding History

Simplify Asset Management’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.16M Buy
278,723
+44,444
+19% +$187K 0.02% 79
2026
Q1 		$972K Buy
+234,279
New +$951K 0.01% 75

Other funds holding AQST

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
ACA
Adirondack Capital Advisors Syracuse, New York $186M AUM
CCM
Cox Capital Management Andover, Massachusetts $180M AUM 40.44% 1-Year Est. Return
LWA
Lineweaver Wealth Advisors Valley View, Ohio $845M AUM 20.71% 1-Year Est. Return
EC
Eleva Capital Paris, France $343M AUM
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
LF
LifeSteps Financial Claremont, California $215M AUM 27.52% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Simplify Asset Management's AQST Position: Q2 2026 in Review

Simplify Asset Management increased its Aquestive Therapeutics (AQST) stake by 19% in Q2 2026, buying an estimated $187K and bringing the position to 278,723 shares worth $1.16M. The position accounts for 0.02% of the portfolio, ranked #79.

Simplify Asset Management first reported a position in AQST in Q1 2026 and has held it in 2 quarters since. 11 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • Simplify Asset Management held 278,723 shares of Aquestive Therapeutics worth $1.16M as of Q2 2026.
  • Simplify Asset Management bought 44,444 Aquestive Therapeutics shares in Q2 2026, an estimated $187K.
  • Aquestive Therapeutics made up 0.02% of Simplify Asset Management's portfolio in Q2 2026, its #79 holding.
  • Simplify Asset Management first reported a position in Aquestive Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 11 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on Simplify Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.